Scientists Claim In Research On Healthcare Workers: Covishield Makes More Antibodies Than Covaxin

Coronavirus Vaccine / Scientists Claim In Research On Healthcare Workers: Covishield Makes More Antibodies Than Covaxin
Coronavirus Vaccine - Scientists Claim In Research On Healthcare Workers: Covishield Makes More Antibodies Than Covaxin
New Delhi: In a research conducted about Corona Vaccine, it has been revealed that compared to Covizen (CovaXin) prepares more antibody (Antibody). Doctors and nurses were included in this research and both of them were made of Covishydal and Covecien. After this it was seen how many vaccines work effectively. According to the results of the research, the Covistructure of the Serum Institute, Bharat Biotech prepares more antibodies than the Coveaken.


So Health Care Workers Included

This study covers a total of 515 health workers (305 men, 210 women). Out of which 456 CoviSHIELD and 96 were installed Covaxin. Overall, 79.3 percent showed seropositivity (seropositivity) after the first DOSE. Scientists found that the response rate in anti-spike antibody and the median rate remained more in Covishield.


Immune Response

In this research called Coronavirus Vaccine-Induced Antibody Titre, such health care workers were included, whether the vaccine has been installed or not. According to Research, both Kovshield and Kowxin promoted good Immune Response (good immune response), and remained more in the median anti-spike antibody covensile. That is, Covisigned creates more antibodies compared to Kovecene.


ICMR also claimed

Earlier, the Indian Council of Medical Research (ICMR) chief Dr. Balram Bhargava (Dr. Balram Bhargava) had a shocking claim about the antibody (antibody) to be made by CovaXin and Covishield. He had said that after taking the first dose of the Covishered Vaccine, it becomes more antibody than the first dose of Covecien. Doctor Bhargava had said that according to the new study, after taking the first doses of Covecien (Covaxin), more antibody is not made, but the second dose manufactures adequate antibodies. At the same time, after taking the first doses of Covishi, it becomes a good number antibody.

Disclaimer

अपनी वेबसाइट पर हम डाटा संग्रह टूल्स, जैसे की कुकीज के माध्यम से आपकी जानकारी एकत्र करते हैं ताकि आपको बेहतर अनुभव प्रदान कर सकें, वेबसाइट के ट्रैफिक का विश्लेषण कर सकें, कॉन्टेंट व्यक्तिगत तरीके से पेश कर सकें और हमारे पार्टनर्स, जैसे की Google, और सोशल मीडिया साइट्स, जैसे की Facebook, के साथ लक्षित विज्ञापन पेश करने के लिए उपयोग कर सकें। साथ ही, अगर आप साइन-अप करते हैं, तो हम आपका ईमेल पता, फोन नंबर और अन्य विवरण पूरी तरह सुरक्षित तरीके से स्टोर करते हैं। आप कुकीज नीति पृष्ठ से अपनी कुकीज हटा सकते है और रजिस्टर्ड यूजर अपने प्रोफाइल पेज से अपना व्यक्तिगत डाटा हटा या एक्सपोर्ट कर सकते हैं। हमारी Cookies Policy, Privacy Policy और Terms & Conditions के बारे में पढ़ें और अपनी सहमति देने के लिए Agree पर क्लिक करें।